Exploring blood biomarkers for monitoring COVID-19 disease progression and outcomes and impact of SARS-CoV-2 variants of concern
In April 2020, the Royal College of Pathologists published recommendations for a set of blood COVID-19 biomarkers to monitor disease severity and progression, which have since been employed by many UK hospital diagnostics services. Subsequent findings regarding biomarkers and their ability to distinguish or predict severe disease remain under investigation and emerging evidence highlights that […]
